Skip to main content
Tessa NewsLink
Paste a health news link, or browse
Latest checks

Source study unconfirmed

Story checked

Weight Loss Continues After Switching From a GLP-1 Shot to a Pill, Study Finds (opens in a new tab)

everydayhealth.com · 2026-09-30

Short answerEvidenceSource

Short answer

Source study unconfirmed

No confirmed study match.

We couldn’t confidently identify the source study behind this story. This leaves its claims unverified — not disproven.

34 candidate papersExplore the search results

These papers were considered as possible sources, but none could be confirmed as the study behind this story.

Share this check

Follow the evidence trail
1
2

NewsLink checks it

No single source study could be confirmed.

We could not identify a single source study for this article. It may discuss broader research or report findings from a source other than a research paper.

Open claim evidence
3

Search result

Source study unconfirmed.

We could not identify a single source study for this article. It may discuss broader research or report findings from a source other than a research paper.

Source paper

Source layer

The 2 papers the story cites

Source study separated from background citations.

The research anchor for the report.

The literature search

34 candidate papers

Papers surfaced in our search

These papers appeared in the search for the story’s source. None was confirmed as a direct match. Inclusion here does not mean a paper supports or contradicts the story, or that its full text was reviewed.

Show 30 more search results
Then inspect each claim

Evidence layer

Claim by claim

What the story asserts. With no source study, there is nothing to check these against.

Claim 1 of 5Not checkedA study presented at the annual meeting of the European Association for the Study of Diabetes found that patients who switched from weekly injectable GLP-1 medications to the daily Wegovy pill lost 4.1 percent of their body weight within the first three months after the change.View evidenceHide evidence

As stated4.1 percent of body weight in three months

Not checked

NewsLink could not identify one source study, so this claim was not compared against a paper.

Claim 2 of 5Not checkedThe study analyzed health records and patient-reported data from Ro, involving 194 people who switched to the Wegovy pill after using injectable semaglutide or tirzepatide.View evidenceHide evidence

As stated194 people

Not checked

NewsLink could not identify one source study, so this claim was not compared against a paper.

Claim 3 of 5Not checkedOn average, patients with obesity lost 8.8 pounds, or 4.1 percent of their body weight, over three months, and the share classified as clinically obese fell from about 87 percent to 65.5 percent.View evidenceHide evidence

As stated8.8 pounds; 4.1 percent; 87 percent to 65.5 percent

Not checked

NewsLink could not identify one source study, so this claim was not compared against a paper.

Claim 4 of 5Not checkedMost patients reported daily use of the oral medication, and 75 percent said they were satisfied with treatment.View evidenceHide evidence

As stated87 percent daily use; 75 percent satisfied

Not checked

NewsLink could not identify one source study, so this claim was not compared against a paper.

Claim 5 of 5Not checkedThe article says the study was not yet peer-reviewed or published, was sponsored by the manufacturer, used real-world data from a single telehealth platform, had no comparison group, and only followed patients for three months.View evidenceHide evidence

As statedthree months; single telehealth platform

Not checked

NewsLink could not identify one source study, so this claim was not compared against a paper.

Finally, the search trail

Method layer

No single source study was found.

The search results are available for you to inspect. Without a confirmed source study, they cannot establish whether the story’s claims are supported or contradicted.

Search results

Candidate papers, not confirmed sources.

PubMed, Europe PMC, Crossref · 34 candidate papers

Explore all search results